TY - BOOK
T1 - Post-translational Modification of Protein Biopharmaceuticals
AU - Walsh, Gary
PY - 2009/9/25
Y1 - 2009/9/25
N2 - From the leading author in the field, known around the world for his work and his authoritative publications, the contents of this book have been selected so as to reflect their relative importance for biopharmaceuticals. As a result, around half of the book is devoted to protein glycosylation, while the remainder is made up of other modifications, such as carboxylation, hydroxylation, sulfation, amidation and proteolytic processing. A final section addresses the latest trend of engineering the modification pattern to improve a given biopharmceutical, presenting several recent case studies of successful posttranslational engineering. This first authoritative overview of the topic is an indispensable guide for drug developers and drug manufacturers with an interest in protein pharmaceuticals.
AB - From the leading author in the field, known around the world for his work and his authoritative publications, the contents of this book have been selected so as to reflect their relative importance for biopharmaceuticals. As a result, around half of the book is devoted to protein glycosylation, while the remainder is made up of other modifications, such as carboxylation, hydroxylation, sulfation, amidation and proteolytic processing. A final section addresses the latest trend of engineering the modification pattern to improve a given biopharmceutical, presenting several recent case studies of successful posttranslational engineering. This first authoritative overview of the topic is an indispensable guide for drug developers and drug manufacturers with an interest in protein pharmaceuticals.
UR - http://www.scopus.com/inward/record.url?scp=77956488043&partnerID=8YFLogxK
U2 - 10.1002/9783527626601
DO - 10.1002/9783527626601
M3 - Book
AN - SCOPUS:77956488043
SN - 9783527320745
BT - Post-translational Modification of Protein Biopharmaceuticals
PB - Wiley-VCH
ER -